Antibodies to COVID-19
Antibody (IgG) to S1 subunit of the spike protein remains relatively stable for 6 months plus
Antibodies to COVID-19
Antibody (IgG) to S1 subunit of the spike protein remains relatively stable for 6 months plus
Antibodies to COVID-19
Antibody (IgG) to S1 subunit of the spike protein remains relatively stable for 6 months plus
Antibodies to COVID-19
Antibody (IgG) to S1 subunit of the spike protein remains relatively stable for 6 months plus
Antibodies to COVID-19
Antibody (IgG) to S1 subunit of the spike protein remains relatively stable for 6 months plus
T cell immunity ( CD4 and CD8 T cells) to SARS-CoV-2/COVID-19 declined with a half life of 3-5 months
Learn MoreAntibodies to COVID-19
Antibody (IgG) to S1 subunit of the spike protein remains relatively stable for 6 months plus
Antibodies to COVID-19
Antibody (IgG) to S1 subunit of the spike protein remains relatively stable for 6 months plus
Antibodies to COVID-19
Antibody (IgG) to S1 subunit of the spike protein remains relatively stable for 6 months plus
Antibodies to COVID-19
Antibody (IgG) to S1 subunit of the spike protein remains relatively stable for 6 months plus